203 related articles for article (PubMed ID: 21679250)
1. Resistance of Helicobacter pylori to quinolones and clarithromycin assessed by genetic testing in Japan.
Yamade M; Sugimoto M; Uotani T; Nishino M; Kodaira C; Furuta T
J Gastroenterol Hepatol; 2011 Sep; 26(9):1457-61. PubMed ID: 21679250
[TBL] [Abstract][Full Text] [Related]
2. Triple therapy with high-dose proton-pump inhibitor, amoxicillin, and doxycycline is useless for Helicobacter pylori eradication: a proof-of-concept study.
Almeida N; Romãozinho JM; Donato MM; Luxo C; Cardoso O; Cipriano MA; Marinho C; Sofia C
Helicobacter; 2014 Apr; 19(2):90-7. PubMed ID: 24506175
[TBL] [Abstract][Full Text] [Related]
3. 10-Year Trends in Helicobacter pylori Eradication Rates by Sitafloxacin-Based Third-Line Rescue Therapy.
Mori H; Suzuki H; Matsuzaki J; Masaoka T; Kanai T
Digestion; 2020; 101(5):644-650. PubMed ID: 31387107
[TBL] [Abstract][Full Text] [Related]
4. Tailored eradication therapy based on fecal Helicobacter pylori clarithromycin sensitivities.
Kawai T; Yamagishi T; Yagi K; Kataoka M; Kawakami K; Sofuni A; Itoi T; Sakai Y; Moriyasu F; Osaka Y; Takagi Y; Aoki T; Rimbara E; Noguchi N; Sasatsu M
J Gastroenterol Hepatol; 2008 Dec; 23 Suppl 2():S171-4. PubMed ID: 19120893
[TBL] [Abstract][Full Text] [Related]
5. Resistance to metronidazole, clarithromycin and levofloxacin of Helicobacter pylori before and after clarithromycin-based therapy in Taiwan.
Chang WL; Sheu BS; Cheng HC; Yang YJ; Yang HB; Wu JJ
J Gastroenterol Hepatol; 2009 Jul; 24(7):1230-5. PubMed ID: 19476562
[TBL] [Abstract][Full Text] [Related]
6. Helicobacter pylori isolates from ethnic minority patients in Guangxi: resistance rates, mechanisms, and genotype.
Zhao LJ; Huang YQ; Chen BP; Mo XQ; Huang ZS; Huang XF; Wei LD; Wei HY; Chen YH; Tang HY; Huang GR; Qin YC; Li XH; Wang LY
World J Gastroenterol; 2014 Apr; 20(16):4761-70. PubMed ID: 24782630
[TBL] [Abstract][Full Text] [Related]
7. Gatifloxacin-based triple therapy as a third-line regimen for Helicobacter pylori eradication.
Nishizawa T; Suzuki H; Nakagawa I; Iwasaki E; Masaoka T; Hibi T
J Gastroenterol Hepatol; 2008 Dec; 23 Suppl 2():S167-70. PubMed ID: 19120892
[TBL] [Abstract][Full Text] [Related]
8. Genotypic resistance in Helicobacter pylori strains correlates with susceptibility test and treatment outcomes after levofloxacin- and clarithromycin-based therapies.
Liou JM; Chang CY; Sheng WH; Wang YC; Chen MJ; Lee YC; Hung HW; Chian H; Chang SC; Wu MS; Lin JT
Antimicrob Agents Chemother; 2011 Mar; 55(3):1123-9. PubMed ID: 21189342
[TBL] [Abstract][Full Text] [Related]
9. Helicobacter pylori Primary Antibiotic Resistance in 2015 in Morocco: A Phenotypic and Genotypic Prospective and Multicenter Study.
Bouihat N; Burucoa C; Benkirane A; Seddik H; Sentissi S; Al Bouzidi A; Elouennas M; Benouda A
Microb Drug Resist; 2017 Sep; 23(6):727-732. PubMed ID: 27996373
[TBL] [Abstract][Full Text] [Related]
10. Vonoprazan-based triple therapy is non-inferior to susceptibility-guided proton pump inhibitor-based triple therapy for Helicobacter pylori eradication.
Tanabe H; Yoshino K; Ando K; Nomura Y; Ohta K; Satoh K; Ichiishi E; Ishizuka A; Otake T; Kohgo Y; Fujiya M; Okumura T
Ann Clin Microbiol Antimicrob; 2018 Jun; 17(1):29. PubMed ID: 29950163
[TBL] [Abstract][Full Text] [Related]
11. Can bacterial virulence factors predict antibiotic resistant
Brennan DE; Dowd C; O'Morain C; McNamara D; Smith SM
World J Gastroenterol; 2018 Mar; 24(9):971-981. PubMed ID: 29531461
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of real-time PCR-based detection of Helicobacter pylori infection and genotypic resistance-guided quadruple therapy as the first-line treatment for functional dyspepsia with Helicobacter pylori infection.
Liu Q; Qi D; Kang J; Jin Y; Liu W; Gao W; Hou P; Lu J
Eur J Gastroenterol Hepatol; 2015 Mar; 27(3):221-5. PubMed ID: 25629566
[TBL] [Abstract][Full Text] [Related]
13. High Prevalence of Helicobacter pylori Resistance to Clarithromycin: a Hospital-Based Cross-Sectional Study in Nakhon Ratchasima Province, Northeast of Thailand.
Tongtawee T; Dechsukhum C; Matrakool L; Panpimanmas S; Loyd RA; Kaewpitoon SJ; Kaewpitoon N
Asian Pac J Cancer Prev; 2015; 16(18):8281-5. PubMed ID: 26745073
[TBL] [Abstract][Full Text] [Related]
14. Clarithromycin-based standard triple therapy can still be effective for Helicobacter pylori eradication in some parts of the Korea.
Yoon KH; Park SW; Lee SW; Kim BJ; Kim JG
J Korean Med Sci; 2014 Sep; 29(9):1240-6. PubMed ID: 25246742
[TBL] [Abstract][Full Text] [Related]
15. Molecular testing for H. pylori clarithromycin and quinolone resistance: a prospective Chinese study.
Zhang C; Cao M; Lv T; Wang H; Liu X; Xie Y; Lv N; Chen H; Cram DS; Zhong J; Zhou L
Eur J Clin Microbiol Infect Dis; 2021 Aug; 40(8):1599-1608. PubMed ID: 33646449
[TBL] [Abstract][Full Text] [Related]
16. Identification and molecular characterization of triple- and quadruple-resistant Helicobacter pylori clinical isolates in Germany.
Wueppenhorst N; Stueger HP; Kist M; Glocker E
J Antimicrob Chemother; 2009 Apr; 63(4):648-53. PubMed ID: 19190100
[TBL] [Abstract][Full Text] [Related]
17. Punctual mutations in
Matta AJ; Zambrano DC; Pazos AJ
World J Gastroenterol; 2018 Apr; 24(14):1531-1539. PubMed ID: 29662291
[TBL] [Abstract][Full Text] [Related]
18. Nonbismuth quadruple (concomitant) therapy: empirical and tailored efficacy versus standard triple therapy for clarithromycin-susceptible Helicobacter pylori and versus sequential therapy for clarithromycin-resistant strains.
Molina-Infante J; Pazos-Pacheco C; Vinagre-Rodriguez G; Perez-Gallardo B; Dueñas-Sadornil C; Hernandez-Alonso M; Gonzalez-Garcia G; Mateos-Rodriguez JM; Fernandez-Bermejo M; Gisbert JP
Helicobacter; 2012 Aug; 17(4):269-76. PubMed ID: 22759326
[TBL] [Abstract][Full Text] [Related]
19. Clarithromycin resistance and female gender affect Helicobacter pylori eradication failure in chronic gastritis.
Chang YW; Ko WJ; Oh CH; Park YM; Oh SJ; Moon JR; Cho JH; Kim JW; Jang JY
Korean J Intern Med; 2019 Sep; 34(5):1022-1029. PubMed ID: 29898576
[TBL] [Abstract][Full Text] [Related]
20. Concomitant therapy achieved the best eradication rate for Helicobacter pylori among various treatment strategies.
Lee HJ; Kim JI; Lee JS; Jun EJ; Oh JH; Cheung DY; Chung WC; Kim BW; Kim SS
World J Gastroenterol; 2015 Jan; 21(1):351-9. PubMed ID: 25574111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
